IBDEI2TJ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47317,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47317,1,4,0)
 ;;=4^C82.03
 ;;^UTILITY(U,$J,358.3,47317,2)
 ;;=^5001464
 ;;^UTILITY(U,$J,358.3,47318,0)
 ;;=C82.04^^209^2346^140
 ;;^UTILITY(U,$J,358.3,47318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47318,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47318,1,4,0)
 ;;=4^C82.04
 ;;^UTILITY(U,$J,358.3,47318,2)
 ;;=^5001465
 ;;^UTILITY(U,$J,358.3,47319,0)
 ;;=C82.05^^209^2346^143
 ;;^UTILITY(U,$J,358.3,47319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47319,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47319,1,4,0)
 ;;=4^C82.05
 ;;^UTILITY(U,$J,358.3,47319,2)
 ;;=^5001466
 ;;^UTILITY(U,$J,358.3,47320,0)
 ;;=C82.06^^209^2346^145
 ;;^UTILITY(U,$J,358.3,47320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47320,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47320,1,4,0)
 ;;=4^C82.06
 ;;^UTILITY(U,$J,358.3,47320,2)
 ;;=^5001467
 ;;^UTILITY(U,$J,358.3,47321,0)
 ;;=C82.07^^209^2346^148
 ;;^UTILITY(U,$J,358.3,47321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47321,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Spleen
 ;;^UTILITY(U,$J,358.3,47321,1,4,0)
 ;;=4^C82.07
 ;;^UTILITY(U,$J,358.3,47321,2)
 ;;=^5001468
 ;;^UTILITY(U,$J,358.3,47322,0)
 ;;=C82.08^^209^2346^147
 ;;^UTILITY(U,$J,358.3,47322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47322,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47322,1,4,0)
 ;;=4^C82.08
 ;;^UTILITY(U,$J,358.3,47322,2)
 ;;=^5001469
 ;;^UTILITY(U,$J,358.3,47323,0)
 ;;=C82.09^^209^2346^141
 ;;^UTILITY(U,$J,358.3,47323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47323,1,3,0)
 ;;=3^Follicular Lymphoma Grade I,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47323,1,4,0)
 ;;=4^C82.09
 ;;^UTILITY(U,$J,358.3,47323,2)
 ;;=^5001470
 ;;^UTILITY(U,$J,358.3,47324,0)
 ;;=C82.10^^209^2346^159
 ;;^UTILITY(U,$J,358.3,47324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47324,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Unspec Site
 ;;^UTILITY(U,$J,358.3,47324,1,4,0)
 ;;=4^C82.10
 ;;^UTILITY(U,$J,358.3,47324,2)
 ;;=^5001471
 ;;^UTILITY(U,$J,358.3,47325,0)
 ;;=C82.11^^209^2346^152
 ;;^UTILITY(U,$J,358.3,47325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47325,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Head/Face/Neck
 ;;^UTILITY(U,$J,358.3,47325,1,4,0)
 ;;=4^C82.11
 ;;^UTILITY(U,$J,358.3,47325,2)
 ;;=^5001472
 ;;^UTILITY(U,$J,358.3,47326,0)
 ;;=C82.12^^209^2346^156
 ;;^UTILITY(U,$J,358.3,47326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47326,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47326,1,4,0)
 ;;=4^C82.12
 ;;^UTILITY(U,$J,358.3,47326,2)
 ;;=^5001473
 ;;^UTILITY(U,$J,358.3,47327,0)
 ;;=C82.13^^209^2346^154
 ;;^UTILITY(U,$J,358.3,47327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47327,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47327,1,4,0)
 ;;=4^C82.13
 ;;^UTILITY(U,$J,358.3,47327,2)
 ;;=^5001474
 ;;^UTILITY(U,$J,358.3,47328,0)
 ;;=C82.14^^209^2346^150
 ;;^UTILITY(U,$J,358.3,47328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47328,1,3,0)
 ;;=3^Follicular Lymphoma Grade II,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47328,1,4,0)
 ;;=4^C82.14
 ;;^UTILITY(U,$J,358.3,47328,2)
 ;;=^5001475
 ;;^UTILITY(U,$J,358.3,47329,0)
 ;;=C82.15^^209^2346^153
 ;;^UTILITY(U,$J,358.3,47329,1,0)
 ;;=^358.31IA^4^2
